HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Rehabilitation Device Helps Reduce Thromboembolism Risk

By HospiMedica International staff writers
Posted on 10 Jun 2014
Image: The VPULSE DVT and PE prevention system (Photo courtesy of Cothera).
Image: The VPULSE DVT and PE prevention system (Photo courtesy of Cothera).
A novel deep vein thrombosis (DVT) prevention device helps hospitals control readmission related costs, while supporting clinician treatment plans.

The VPULSE System is single user, postsurgical rehabilitation device designed to prevent venous thromboembolism (VTE) and subsequent pulmonary embolism (PE) in the hospital, clinic, and home environments. The system consists of a control unit, tubing set, and a choice of various joint-specific application wraps that deliver the therapeutic treatments. These include intermittent pneumatic compression (IPC) therapy to prevent hospital-acquired VTE; intermittent dynamic compression therapy to reduce swelling; and controlled cold therapy to reduce pain and swelling.

Each of the separate treatment modalities is considered essential for effective postoperative rehabilitation and the prevention of complications. The patient can apply one or two sequential compression therapy pads to the calves for preventative treatment of VTE; and/or one thermal-compression pad to a specific body part such as the knee or shoulder for cold therapy; and/or dynamic compression therapy to manage pain and swelling for post-operative recovery. The VPULSE System is a product of Cothera (Plano, TX, USA), and has received the European Community CE marking of approval.

“The VPULSE System combines DVT prevention and post-orthopedic procedure rehabilitation and places these effective therapies and significant convenience in the hands of the patients,” said Howard Edelman, general manager of Cothera. “The fact that the VPULSE can be used continuously from the hospital to home setting, while providing physicians with compliance data via a data card, will dramatically reduce instances of DVT complications.”

DVT refers to the development of blood clots, or thrombi, within a deep vein. Typically it occurs in the thigh or calf and can develop after any major surgery. Symptoms may include pain, swelling, skin discoloration, or no signs at all. DVT risk is greatest between two and five days after surgery, with a second peak risk period at about 10 days after surgery (after the patient has been discharged). A consecutive PE can occur when a clot breaks free and lodges in the lungs. PE has been reported to occur in over one third of DVT patients and frequently causes sudden death.

Related Links:

Cothera


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more